KN

Krishnammal Nagarajan Shyamala Umaapathy

Active Director Director DIN 07353949
DIN 07353949 First appointment Sep 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Krishnammal Nagarajan Shyamala Umaapathy

Data last updated:

Krishnammal Nagarajan Shyamala Umaapathy is a Director at Subhi Subhiksham Hospitals Private Limited (since 2025).

DIN 07353949
Primary Designation Director
First Appointment 17 Sep 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Sep 20252025Active

Board colleagues of Krishnammal Nagarajan Shyamala Umaapathy

Directorship timeline

Open interactive timeline →
Subhi Subhiksham Hospitals Private Limited
Premium access

Shareholding and investment profile for Krishnammal Nagarajan Shyamala Umaapathy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Krishnammal Nagarajan Shyamala Umaapathy

Krishnammal Nagarajan Shyamala Umaapathy currently holds 1 directorship: Subhi Subhiksham Hospitals Private Limited (Director, since 17 Sep 2025).

Krishnammal Nagarajan Shyamala Umaapathy was first appointed on 17 Sep 2025 as Director at Subhi Subhiksham Hospitals Private Limited.

The current boards of Krishnammal Nagarajan Shyamala Umaapathy's companies include Karpagambharathi (Subhi Subhiksham Hospitals Private Limited), Prasanna (Subhi Subhiksham Hospitals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available